[BREAKING] Hemerion obtains the FDA clearance for its next US clinical trial


Press releases

July 4, 2023

Hemerion announces FDA clearance of IND application for its Pentalafen® / Heliance® combination product in the treatment of glioblastoma, the most aggressive primary brain tumor
Read the Press Release

April 12, 2023

Cancer treatment: Hemerion secures an additional €2 million in funding from Bpifrance
Read the Press Release

April 14, 2022

Hemerion Therapeutics successfully raises over €3.5 million: a new hope for the treatment of brain cancer.
Read the Press Release

October 28, 2021

Hemerion and Mount Sinai Hospital awarded the Galien MedStartup Prize for “Best Collaboration in the MedTech and Digital Health” category
Read the Press Release

March 22, 2021

Positive preliminary clinical results for the treatment of glioblastoma developed by Hemerion
Read the Press Release

They talk about us

Les Echos

June 7, 2023

Hemerion makes progress with its laser therapy for brain cancer

Read the article

Logo Arte

April, 2023

Hopes of laser therapy in the battle against brain tumors

Read the article

Logo Sciences et Avenir La Recherche

September, 2022

Innovative medicine / Light-based treatments

Read the article

Les Echos

May 05, 2022

Hemerion tests innovative laser therapy for brain cancer

Read the article

Eco 121

May 02, 2022

How to revolutionize tomorrow’s health care?

Read the article

Allo Docteurs

March 31, 2022

Glioblastoma: an innovative laser treatment

Read the article

La voix du Nord

May, 2022

Hemerion aims to increase survival for brain cancer patients

Read the article

Logo CF News

April 15, 2022

Hemerion takes on glioblastoma

Read the article

Journal of Neuro-Oncology

May, 2021

Hemerion on the cover of the May Journal of Neuro-Oncology

Read the article


April, 2021

Tumor cells destroyed by laser by Hemerion Therapeutics

Read the article

Le quotidien du médecin

February 23, 2021

When glioblastoma sees red

Read the article

Device Med

February 15, 2021

Hemerion Therapeutics wins award for therapeutic innovation

Read the article


Maximilien Vermandel


Maximilien Vermandel

This field is for validation purposes and should be left unchanged.

mail icon

Stay tuned to our clinical advances

Subscribe to our newsletter